<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02768610</url>
  </required_header>
  <id_info>
    <org_study_id>110757-201602-HR-03-03</org_study_id>
    <nct_id>NCT02768610</nct_id>
  </id_info>
  <brief_title>Use of Preanesthetic Dexmedetomidine in Elderly, Treated-hypertensive Patients</brief_title>
  <official_title>Effects of Preanesthetic Dexmedetomidine on Hemodynamic Responses to Endotracheal Intubation in Elderly Patients Being Treated for Hypertension: A Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>DongGuk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DongGuk University</source>
  <brief_summary>
    <textblock>
      Background: Dexmedetomidine is an alpha 2 adrenergic agonist with sedative, anxiolytic, and
      analgesic properties. This study was designed to evaluate the inhibitory effects of
      preoperative 0.5 μg/kg dexmedetomidine on hemodynamic responses caused by endotracheal
      intubation in elderly patients being treated for hypertension.

      Methods: Forty elderly (≥ 65 years) treated-hypertensive patients of American Society of
      Anesthesiologists physical status II undergoing elective noncardiac surgery were randomly and
      assigned to two groups. Group C received normal saline and group D received 0.5 μg/kg
      dexmedetomidine intravenously over 10 min just before endotracheal intubation. Systolic blood
      pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) and heart rate
      (HR) were recorded preoperatively at ward, immediately after study drug administration, and
      at 1, 3, and 5 minutes after endotracheal intubation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in systolic blood pressure</measure>
    <time_frame>2 minutes before intubation and 1, 3, 5 minutes after intubation</time_frame>
    <description>Units of Measure : mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in diastolic blood pressure</measure>
    <time_frame>2 minutes before intubation and 1, 3, 5 minutes after intubation</time_frame>
    <description>Units of Measure : mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in mean arterial pressure</measure>
    <time_frame>2 minutes before intubation and 1, 3, 5 minutes after intubation</time_frame>
    <description>Units of Measure : mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in heart rate</measure>
    <time_frame>2 minutes before intubation and 1, 3, 5 minutes after intubation</time_frame>
    <description>Units of Measure : beats/min</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Perioperative Care</condition>
  <arm_group>
    <arm_group_label>dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5 mcg/kg dexmedetomidine is administered before endotracheal intubation for 10 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <arm_group_label>dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <arm_group_label>Normal Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists physical status II

          -  Scheduled for elective noncardiac surgery

          -  Being treated with anti-hypertensive medication

        Exclusion Criteria:

          -  Endotracheal intubation attempted more than twice

          -  Morbidly obese (BMI &gt; 35 kg/m2)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miwoon Kim, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>DongGuk universit hospital Gyeongju hospital</affiliation>
  </overall_official>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2016</study_first_submitted>
  <study_first_submitted_qc>May 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2016</study_first_posted>
  <last_update_submitted>May 9, 2016</last_update_submitted>
  <last_update_submitted_qc>May 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>DongGuk University</investigator_affiliation>
    <investigator_full_name>Chanwoo Lee</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

